Nearly half of Asia-Pacific AMR plans remain uncosted
WHAT HAPPENED
WHO and Japan's regional data from 28 countries show that 27 have endorsed at least one multisectoral antimicrobial-resistance plan. Second-generation plans with monitoring frameworks rose from 33% to 93%, and those wit…
Read the full summary & background
WHO and Japan's regional data from 28 countries show that 27 have endorsed at least one multisectoral antimicrobial-resistance plan. Second-generation plans with monitoring frameworks rose from 33% to 93%, and those with measurable targets from 8% to 71%. Yet 49% of current plans are still uncosted and only eight countries fully fund activities domestically; just 16 report basic water, sanitation and hygiene in more than 75% of health facilities, while only nine say Access antibiotics exceed 70% of use. Governance is improving, but financing and delivery remain the gap.
A public-health plan matures only when budgets, facilities and prescribing behavior change together.
Doudoulong, in plain words
Having a plan is not execution; the 49% uncosted share is the clearest risk signal.
AI-assisted illustration · not a documentary photograph
